Application 211035
- Type
- ANDA
- Sponsor
- SOMERSET
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | SOLUTION;INTRAVENOUS | 5MG/2ML (2.5MG/ML) | No | No |
| 002 | VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | SOLUTION;INTRAVENOUS | 10MG/4ML (2.5MG/ML) | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 70069-273 | Verapamil Hydrochloride | Verapamil Hydrochloride | Somerset Therapeutics, LLC | ANDA | Current |
| 70069-273 | Verapamil Hydrochloride | Verapamil Hydrochloride | Somerset Therapeutics, LLC | ANDA | Current |
| 70069-273 | Verapamil Hydrochloride | Verapamil Hydrochloride | Somerset Therapeutics, LLC | ANDA | Current |
| 70069-273 | Verapamil Hydrochloride | Verapamil Hydrochloride | Somerset Therapeutics, LLC | ANDA | Current |
| 70069-273 | Verapamil Hydrochloride | Verapamil Hydrochloride | Somerset Therapeutics, LLC | ANDA | Current |